Christopher Bahl: A new type of medicine, custom-made with tiny proteins

The video discusses constrained peptides, a new type of molecule used in drug development. These peptides are small proteins with extra chemical bonds, making them stable and potent. Unlike traditional biologics, constrained peptides can be administered in various forms, such as pills or ointments. The video explains the challenges of designing new constrained peptides and highlights a collaborative effort to create them from scratch using open-source software. The potential applications of these peptides include treating influenza, botulism, and cancer, with some already in pre-clinical trials.

What innovative approach was taken to design new constrained peptides?

Discuss the potential future impact of designed peptide drugs on disease treatment.